MacDonald, J
Blend: DSIP / Pinealon / Epitalon Strength Per Spray: 150MCG / 250MCG / 200MCG DSIP Content: 150MCG per spray Pinealon Content: 250MCG per spray Epitalon Content: 200MCG per spray Spray Count: Approximately 100 sprays Total DSIP Content: 15MG Total Pinealon Content: 25MG Total Epitalon Content: 20MG Total Peptide Content: 60MG Format: cGMP-made Aerosol research spray Research Category: Neuropeptide / pineal peptide / circadian pathway research Research Focus: Sleep-wake pathway models, CNS signaling, pineal peptide biology, circadian rhythm research, cellular aging pathway models, oxidative stress biology, and peptide-fragment response systems
The clinical research demonstrates that Semaglutide, which mimics the in vivo biological activity of the gut hormone GLP-1, act[s] as a satiety factor peripheral administration of GLP-1 inhibits food intake. The causal mechanism responsible for GLP-1s satiating effects is its signaling activity on the web of hormones responsible for the feeding impulse: In addition, interventricular injections of GLP-1 inhibit food intake, independent of the presence of food in the stomach or gastric emptying the synergistic actions of GLP-1 in the gut and brain, acting on both central and peripheral receptors that [are] responsible for the effects of the hormone on satiety. Academic References Semaglutide for weight loss. Accessed via Effects of GLP-1 on appetite and weight. Accessed via Appetite Regulation, Neuronal Control. Accessed via Once-weekly Ozempic mechanism of action. Accessed via Once-Weekly Semaglutide in Adults with Overweight or Obesity. Accessed via Contraindications Per pharmaceutical guidelines, individuals with certain health conditions should avoid Semaglutide
42 The drug targets both M1 and M4 muscarinic receptors, which play a key role in various psychiatric and neurological disorders
The human protein atlas
Does GLP-1 Keep the Weight Off Forever
.png)
